BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38236447)

  • 1. 8-Br-cGMP suppresses tumor progression through EGFR/PLC γ1 pathway in epithelial ovarian cancer.
    Wu M; Mu C; Yang H; Wang Y; Ma P; Li S; Wang Z; Lan T
    Mol Biol Rep; 2024 Jan; 51(1):140. PubMed ID: 38236447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased endogenous PKG I activity attenuates EGF-induced proliferation and migration of epithelial ovarian cancer via the MAPK/ERK pathway.
    Lan T; Li Y; Wang Y; Wang ZC; Mu CY; Tao AB; Gong JL; Zhou Y; Xu H; Li SB; Gu B; Ma P; Luo L
    Cell Death Dis; 2023 Jan; 14(1):39. PubMed ID: 36653376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PKG II inhibits EGF/EGFR-induced migration of gastric cancer cells.
    Jiang L; Lan T; Chen Y; Sang J; Li Y; Wu M; Tao Y; Wang Y; Qian H; Gu L
    PLoS One; 2013; 8(4):e61674. PubMed ID: 23613900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cGMP-dependent protein kinase by the cell-permeable peptide DT-2 reveals a novel mechanism of vasoregulation.
    Taylor MS; Okwuchukwuasanya C; Nickl CK; Tegge W; Brayden JE; Dostmann WR
    Mol Pharmacol; 2004 May; 65(5):1111-9. PubMed ID: 15102939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclic guanosine 5'-monophosphate-dependent protein kinase I (PKG-I) in lumbar spinal cord reduces formalin-induced hyperalgesia and PKG upregulation.
    Schmidtko A; Ruth P; Geisslinger G; Tegeder I
    Nitric Oxide; 2003 Mar; 8(2):89-94. PubMed ID: 12620371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of mitogen-activated protein kinase pathways by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells.
    Komalavilas P; Shah PK; Jo H; Lincoln TM
    J Biol Chem; 1999 Nov; 274(48):34301-9. PubMed ID: 10567406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II cGMP-dependent protein kinase phosphorylates EGFR at threonine 669 and thereby inhibits its activation.
    Lan T; Pang J; Wang Z; Wang Y; Qian H; Chen Y; Wu Y
    Biochem Biophys Res Commun; 2019 Oct; 518(1):14-18. PubMed ID: 31395339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide/cyclic guanosine monophosphate inducers sodium nitroprusside and L-arginine inhibit the proliferation of gastric cancer cells via the activation of type II cyclic guanosine monophosphate-dependent protein kinase.
    Yao X; Wu Y; Zhu M; Qian H; Chen Y
    Oncol Lett; 2015 Jul; 10(1):479-484. PubMed ID: 26171055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase G type Ialpha activity in human ovarian cancer cells significantly contributes to enhanced Src activation and DNA synthesis/cell proliferation.
    Leung EL; Wong JC; Johlfs MG; Tsang BK; Fiscus RR
    Mol Cancer Res; 2010 Apr; 8(4):578-91. PubMed ID: 20371672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of four cGMP analogues with different mechanisms of action on hormone release by porcine ovarian granulosa cells in vitro.
    Sirotkin AV; Makarevich AV; Genieser HG; Kotwica J; Hetényi L
    Exp Clin Endocrinol Diabetes; 2000; 108(3):214-9. PubMed ID: 10926319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKG II effectively reversed EGF-induced protein expression alterations in human gastric cancer cell lines.
    Qian H; Tao Y; Jiang L; Wang Y; Lan T; Wu M; Pang J; Appiah-Kubi K; Chen Y; Wu Y
    Cell Biol Int; 2018 Apr; 42(4):435-442. PubMed ID: 29150923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic Guanosine Monophosphate (cGMP)-Dependent Protein Kinase II Blocks Epidermal Growth Factor (EGF)/Epidermal Growth Factor Receptor (EGFR)-Induced Biological Effects on Osteosarcoma Cells.
    Li D; Hua Y; Jiang L; Huang Y; Yue J; Wu Y; Chen Y
    Med Sci Monit; 2018 Apr; 24():1997-2002. PubMed ID: 29617357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of spontaneous contractile activity in the bovine epididymal duct by cyclic guanosine 5'-monophosphate-dependent pathways.
    Mewe M; Bauer CK; Müller D; Middendorff R
    Endocrinology; 2006 Apr; 147(4):2051-62. PubMed ID: 16439452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines.
    Fallahian F; Karami-Tehrani F; Salami S; Aghaei M
    FEBS J; 2011 Sep; 278(18):3360-9. PubMed ID: 21777390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic GMP specifically suppresses Type-Ialpha cGMP-dependent protein kinase expression by ubiquitination.
    Dey NB; Busch JL; Francis SH; Corbin JD; Lincoln TM
    Cell Signal; 2009 Jun; 21(6):859-66. PubMed ID: 19168131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of leukocyte degranulation by cGMP-dependent protein kinase and phosphoinositide 3-kinase: potential roles in phosphorylation of target membrane SNARE complex proteins in rat mast cells.
    Nanamori M; Chen J; Du X; Ye RD
    J Immunol; 2007 Jan; 178(1):416-27. PubMed ID: 17182580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of the cGMP/PKG signaling pathway in regulating the proliferation and survival of human renal carcinoma cells.
    Ren Y; Zheng J; Yao X; Weng G; Wu L
    Int J Mol Med; 2014 Nov; 34(5):1430-8. PubMed ID: 25244411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent inhibitory effects of cGMP-analogues on thrombin-induced platelet-derived microparticles formation, platelet aggregation, and P-selectin expression.
    Nygaard G; Herfindal L; Kopperud R; Aragay AM; Holmsen H; Døskeland SO; Kleppe R; Selheim F
    Biochem Biophys Res Commun; 2014 Jul; 449(3):357-63. PubMed ID: 24845383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the small GTPase Rac1 by cGMP-dependent protein kinase.
    Hou Y; Ye RD; Browning DD
    Cell Signal; 2004 Sep; 16(9):1061-9. PubMed ID: 15212766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PLCγ1‑dependent invasion and migration of cells expressing NSCLC‑associated EGFR mutants.
    Mittal S; Kamath A; Joseph AM; Rajala MS
    Int J Oncol; 2020 Oct; 57(4):989-1000. PubMed ID: 32945365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.